您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Ebvaciclib(PF-06873600)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Ebvaciclib(PF-06873600)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Ebvaciclib(PF-06873600)图片
CAS NO:2185857-97-8
规格:≥98%
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍
理化性质和储存条件


Name: PF-06873600
CAS#: 2185857-97-8
Chemical Formula: C20H27F2N5O4S
Exact Mass: 471.1752
Molecular Weight: 471.5238
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Technical InformationSynonym: PF06873600; Ebvaciclib; PF 06873600; PF-06873600;
Chemical Name: Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-(difluoromethyl)-8-[(1R,2R)-2-hydroxy-2-methylcyclopentyl]-2-[[1-(methylsulfonyl)-4-piperidinyl]amino]-
InChi Key: QIEKHLDZKRQLLN-FOIQADDNSA-N
InChi Code: InChI=1S/C20H27F2N5O4S/c1-20(29)7-3-4-15(20)27-17-12(10-14(16(21)22)18(27)28)11-23-19(25-17)24-13-5-8-26(9-6-13)32(2,30)31/h10-11,13,15-16,29H,3-9H2,1-2H3,(H,23,24,25)/t15-,20-/m1/s1
SMILES Code: O=C1C(C(F)F)=CC2=CN=C(NC3CCN(S(=O)(C)=O)CC3)N=C2N1[C@H]4[C@](C)(O)CCC4
实验参考方法
In Vitro

PF-06873600 (PF06873600) is a novel, potent, selective and orally bioavailable inhibitor of cyclin-dependent kinase (CDK) with potential antitumor activity. It inhibits CDK2, CDK4 and CDK6 with Ki values of 0.09 nM, 0.13 nM and 0.16 nM, respectively. PF-06873600 exhibits antineoplastic activity by selectively binding to and inhibiting the activity of CDKs. Inhibition of these kinases leads to cell cycle arrest, induction of apoptosis and inhibition of tumor cell proliferation. CDKs, ATP-dependent serine/threonine kinases that are important regulators of cell cycle progression and cellular proliferation, are frequently overexpressed in tumor cells.

PF-06873600 (Example 8) is an orally bioavailable, cyclin-dependent kinase (CDK) inhibitor, with potential antineoplastic activity[1]. PF-06873600 selectively targets, binds to and inhibits the activity of CDKs. Inhibition of these kinases leads to cell cycle arrest, induction of apoptosis and inhibition of tumor cell proliferation. CDKs, ATP-dependent serine/threonine kinases that are important regulators of cell cycle progression and cellular proliferation, are frequently overexpressed in tumor cells[2].

References

[1]. US 2018/0044344 A1.

[2]. NCI Drug Dictionary